Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06934226
What this trial is testing

Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 752
Testing effectiveness (Phase 2)UnknownNCT00295425
What this trial is testing

CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

Who this might be right for
Psoriasis
University Hospital Muenster 50
Post-approval studies (Phase 4)Ended earlyNCT01543204
What this trial is testing

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

Who this might be right for
Psoriasis
Amgen 64
Testing effectiveness (Phase 2)Study completedNCT00428974
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 76
Testing effectiveness (Phase 2)Study completedNCT01483599
What this trial is testing

Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Inc. 293
Not applicableUnknownNCT02174367
What this trial is testing

An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis

Who this might be right for
Psoriasis ChronicLiver FibrosisFatty Liver+1 more
King's College London 400
Post-approval studies (Phase 4)Study completedNCT00936065
What this trial is testing

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
Pfizer 60
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Post-approval studies (Phase 4)UnknownNCT03307447
What this trial is testing

Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).

Who this might be right for
Psoriasis Vulgaris
Narrows Institute for Biomedical Research 30
Testing effectiveness (Phase 2)Study completedNCT06061471
What this trial is testing

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 454
Very early researchLooking for participantsNCT07337434
What this trial is testing

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Who this might be right for
Chronic Plaque Psoriasis
Syeda Sana Zaman 106
Early research (Phase 1)Study completedNCT01276847
What this trial is testing

Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 40
Not applicableStudy completedNCT03511755
What this trial is testing

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Who this might be right for
PsoriasisStress
Thync Global, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02576678
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 42
Not applicableStudy completedNCT00769184
What this trial is testing

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Who this might be right for
Psoriasis
NeoStrata Company, Inc. 15
Large-scale testing (Phase 3)UnknownNCT06477237
What this trial is testing

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Huabo Biopharm Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT04123795
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis
UCB Biopharma SRL 49
Not applicableStudy completedNCT01435265
What this trial is testing

Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 7
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT04453137
What this trial is testing

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 567
Next Page